Shots:AI Medical Technology has reported the CE mark approval of Dermalyser for melanoma detection; commercialization to begin in 2025Dermalyser was validated in AI-DSMM study across 36 Swedish centers, where it analyzed 253 suspicious lesions in 228 pts, identifying 21 melanomas (11 as thin invasive & 10 as in situ). It also achieved AUROC…
